Therefore, the intensity of APE1 protein expression was associated with the efficacy of multiple myeloma, suggesting a potential role of enhanced APE1 gene expression in multiple myeloma resistance to melphalan. This evidence concerns the gene APEX1 and AL amyloidosis.